Viewing Study NCT00171132


Ignite Creation Date: 2025-12-24 @ 9:29 PM
Ignite Modification Date: 2026-01-19 @ 12:28 AM
Study NCT ID: NCT00171132
Status: COMPLETED
Last Update Posted: 2017-02-23
First Post: 2005-09-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Postmenopausal View
None women View
None overweight View
None hypertension View
None impaired View
None exercise View
None capacity View
None valsartan View
None atenolol View
None hydrochlorothiazide View